Search
Selected Filter
Displaying 1–10 of 33 news results
-
Foundation Fighting Blindness Celebrates 15th Year of VisionWalk with New Branding
This signature fundraising event has raised more than $55 million for research leading to treatments and cures for blindness.
-
Offer support to patients with inherited eye diseases
While genetic testing can direct treatment and identify those at risk, it is important to have support available when patients test positive.
-
Returning the favor: Never too late to give back as a premium surgeon
Whether local or international, through donation of services or funds, there is a way for everyone to give back.
-
Known as Pro-EYS, the study will help researchers design clinical trials for potential therapies
-
Foundation Fighting Blindness InSights Forum Call
The Foundation Fighting Blindness is pleased to provide an audio recording and full transcripts of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on October 30, 2019.
-
The program will offer patients with inherited retinal disease no-cost genetic testing and genetic counseling in the United States. Look for updated information on how to participate to be posted in mid-October, with program registration starting shortly thereafter.
-
Foundation Fighting Blindness Investing Nearly $6.5 Million in New Grants
The newly funded research efforts include several therapies that have strong potential to treat a wide range of inherited retinal diseases.
-
Foundation Fighting Blindness InSights Forum Call
The Foundation Fighting Blindness is pleased to provide an audio recording and full transcripts of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on July 24, 2019.
-
Foundation Fighting Blindness Appoints Judy Taylor Vice President, Development
Ms. Taylor brings over twenty-five years of successful non-profit experience, including executive-level positions, to Foundation
-
Sustained Suppression of VEGF: Looking Forward and Looking Back
The results of the LADDER trial demonstrate a major step forward but introduce many questions.
